Vivimed Labs gains on stock-split plan

Vivimed Labs rose 1.09% to Rs 372 at 14:05 IST on BSE after the company said its board of directors would meet on 11 January 2016, to consider a stock-split proposal.

The company made the announcement during trading hours today, 17 December 2015.

Meanwhile, the BSE Sensex was up 189.42 points, or 0.74%, to 25,683.79

On BSE, so far 56,370 shares were traded in the counter, compared with an average volume of 54,274 shares in the past one quarter.

The stock hit a high of Rs 431.10 and a low of Rs 420 so far during the day. The stock hit a record high of Rs 446 on 1 December 2015. The stock hit a 52-week low of Rs 175 on 24 June 2015.

The stock had outperformed the market over the past one month till 16 December 2015, rising 12.96% compared with Sensex's 1.03% fall. The scrip had also outperformed the market in past one quarter, gaining 45.33% as against Sensex's 1.81% fall.

The small-cap company has an equity capital of Rs 16.20 crore. Face value per share is Rs 10.

Vivimed Labs' consolidated net profit rose 45.5% to Rs 23.88 crore on 7.5% rise in net sales to Rs 337.03 crore in Q2 September 2015 over Q2 September 2014.

Vivimed Labs is a leading manufacturer and exporter of specialty chemicals mainly used in the personal-care and pharmaceutical industries.

Powered by Capital Market - Live News